American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...

New study shows tirzepatide reduces LV mass and heart fat in obesity-related HFpEF, potentially improving heart failure outcomes.

Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

The FDA and the U.S. Customs and Border Protection records show 239 shipments of semaglutide and tirzepatide — the active ...

Researchers found that women with hypertension who followed a very low-calorie ketogenic diet had lower systolic and diastolic blood pressure at 6 months than those who participated in intermittent ...

“Oh my God, you don’t need it.” “I’ve gained 20 pounds since going into menopause, all in my gut!” “It’s for people with ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

Online pharmacies must now conduct in-person consultations before dispensing weight-loss medications, ensuring safe and appropriate use of high-risk drugs.

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...